Kelonia Therapeutics
Presence
Acquisition, funding and merger involving Kelonia Therapeutics.
- Kelonia Therapeutics has just announced a $50 Million fundraising (posted on April 29 2022).
Executives
View the org chart displaying its 20 main executives
Most searched biographies at Kelonia Therapeutics
Popular executive movements at Kelonia Therapeutics
- Mathai Mammen has joined the company as Director (posted on March 29 2024).
- Kristen Hege has joined the company as Director (posted on March 29 2024).
- Sarah Tannehill-Gregg has joined the company as Vice President, Nonclinical Development (posted on February 6 2024).
Click here to view some more movements at Kelonia Therapeutics
Create your alert
to follow the executive moves at Kelonia Therapeutics.
Biotechnology
Kelonia Therapeutics has 2,279 competitors including Eurofins (Luxembourg), Lonza (Switzerland) and Adaptive Phage Therapeutics (United States (USA)).
Popular M&A news in Biotechnology
- Metsera has just announced a $290 Million fundraising (posted on April 23 2024).
- Histogen has filed for bankruptcy protection (posted on April 19 2024).
- Bruker has announced the acquisition of NanoString Technologies (posted on April 18 2024).
Popular contacts in Biotechnology
News
Press releases by Kelonia Therapeutics
- Astellas and Kelonia Partner for $800M In Vivo CAR T Cell Therapies
- Astellas teams up with startup Kelonia to make ‘in vivo’ cell therapies
- Gene therapy targeting T-cells shows promise in myeloma models |...
- ASGCT News: Kelonia Lentiviral Particles May Solve In Vivo Delivery Hurdles for CAR T Cells
- As Cell Therapy Gains Ground, Efforts Emerge to Improve CAR T-Manufacturing - MedCity News
Social media about Kelonia Therapeutics
- Kelonia Therapeutics on Wikipedia, Google News & Yahoo Finance
- Kelonia Therapeutics on LinkedIn, Twitter & YouTube
Get in Touch
Contact by email its executives including Michael Birnbaum 
Call Kelonia Therapeutics at +1 315...
